Contribution of STAT3 to the pathogenesis of COVID-19

被引:70
作者
Jafarzadeh, Abdollah [1 ,2 ]
Nemati, Maryam [3 ,4 ]
Jafarzadeh, Sara [5 ]
机构
[1] Kerman Univ Med Sci, Sch Med, Dept Immunol, Kerman, Iran
[2] Rafsanjan Univ Med Sci, Sch Med, Dept Immunol, Rafsanjan, Iran
[3] Rafsanjan Univ Med Sci, Immunol Infect Dis Res Ctr, Res Inst Basic Med Sci, Rafsanjan, Iran
[4] Kerman Univ Med Sci, Sch Paramed, Dept Hematol & Lab Sci, Kerman, Iran
[5] Kerman Univ Med Sci, Sch Med, Student Res Comm, Kerman, Iran
关键词
COVID-19; SARS-CoV-2; STAT3; Pathogenesis; Inflammation; Immune response; Treatment; IL-6; DIFFERENTIATION; INTERLEUKIN-6; INFLAMMATION; ACTIVATION; PROTEIN; INJURY;
D O I
10.1016/j.micpath.2021.104836
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hyper-inflammatory responses, lymphopenia, unbalanced immune responses, cytokine storm, large viral replication and massive cell death play fundamental roles in the pathogenesis of COVID-19. Extreme production of many kinds of pro-inflammatory cytokines and chemokines occur in severe COVID-19 that called cytokine storm. Signal transducer and activator of transcription-3 (STAT-3) present in the cytoplasm in an inactive form and can be stimulated by a vast range of cytokines, chemokines and growth factors. Thus, STAT-3 can participate in the induction of inflammatory responses during coronavirus infections. STAT-3 can also suppress anti-virus interferon response and induce unbalanced anti-virus adaptive immune response, through influencing Th17-, Th1-, Treg-, and B cell-mediated functions. Furthermore, STAT-3 can contribute to the M2 macrophage polarization, lung fibrosis and thrombosis. Moreover, STAT-3 may be directly targeted by some virus-derived protein and operate as a pro-viral or anti-viral element in a virus-specific process. Here, the possible contribution of STAT-3 to the pathogenesis of COVID-19 was explained, while providing potential approaches to target this transcription factor in an attempt for COVID-19 treatment.
引用
收藏
页数:8
相关论文
共 112 条
  • [1] Overexpression of OSM and IL-6 impacts the polarization of profibrotic macrophages and the development of bleomycin-induced lung fibrosis
    Ayaub, Ehab A.
    Dubey, Anisha
    Imani, Jewel
    Botelho, Fernando
    Kolb, Martin R. J.
    Richards, Carl D.
    Ask, Kjetil
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [2] Barrett D, 2019, CYTOKINE STORM SYNDROME, P561, DOI 10.1007/978-3-030-22094-5_32
  • [3] Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8
    Bester, Janette
    Matshailwe, Christina
    Pretorius, Etheresia
    [J]. CYTOKINE, 2018, 110 : 237 - 242
  • [4] STAT3 roles in viral infection: antiviral or proviral?
    Chang, Zhangmei
    Wang, Yan
    Zhou, Xin
    Long, Jian-Er
    [J]. FUTURE VIROLOGY, 2018, 13 (08) : 557 - 574
  • [5] Clinical and immunological features of severe and moderate coronavirus disease 2019
    Chen, Guang
    Wu, Di
    Guo, Wei
    Cao, Yong
    Huang, Da
    Wang, Hongwu
    Wang, Tao
    Zhang, Xiaoyun
    Chen, Huilong
    Yu, Haijing
    Zhang, Xiaoping
    Zhang, Minxia
    Wu, Shiji
    Song, Jianxin
    Chen, Tao
    Han, Meifang
    Li, Shusheng
    Luo, Xiaoping
    Zhao, Jianping
    Ning, Qin
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05) : 2620 - 2629
  • [6] A potential treatment of COVID-19 with TGF-β blockade
    Chen, WanJun
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (11): : 1954 - 1955
  • [7] Chen X., 2020, CLIN INFECT DIS, V71, P1942
  • [8] Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome
    Chen, Xuxin
    Tang, Jian
    Shuai, Weizheng
    Meng, Jiguang
    Feng, Jian
    Han, Zhihai
    [J]. INFLAMMATION RESEARCH, 2020, 69 (09) : 883 - 895
  • [9] Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis
    Cimmino, Giovanni
    Cirillo, Plinio
    [J]. CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2018, 8 (05) : 581 - 593
  • [10] A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
    Day, Craig W.
    Baric, Ralph
    Cai, Sui Xiong
    Frieman, Matt
    Kumaki, Yohichi
    Morrey, John D.
    Smee, Donald F.
    Barnard, Dale L.
    [J]. VIROLOGY, 2009, 395 (02) : 210 - 222